Bendamustine in the treatment of chronic lymphocytic leukemia. 30. Mai 2009 Knauf, W., 2009 Expert Rev Anticancer Ther 9, 165–174. doi:10.1586/14737140.9.2.165 Abstract The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. Hadji, P., Ziller, M., Kieback, D.G., Menschik, T., Kalder, M., Kuck, J., Hasenburg, A., 2009. Breast 18, 159–164. doi:10.1016/j.breast.2009.03.003 Abstract… Weiterlesen Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. Knauf, W.U., Lissichkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Fricke, H.-J., Huguet,… Weiterlesen